Multiplex Detection Immunoassay Market Expected to Touch US$ 3.0 Bn by 2024 | Page 3

R e s e a r c h
M a r k e t

Download Report Table of Content, Figures, and Tables @

http://www.persistencemarketresearch.com/market-research/multiplex-detectionimmunoassay-market/toc
Based on application, the market has been segmented into disease testing (infectious disease,
autoimmune disease, and others), food contamination testing, drug development and veterinary
disease testing. Drug development currently accounts for the highest revenue share in the
market followed by disease testing. Increasing focus on disease predisposition studies and drug
efficacy studies would create a good opportunity for growth of multiplex detection immunoassay
market.
Based on end users, the market has been segmented into pharmaceutical companies, clinical
research organizations, food & beverages companies, academic research institutes, diagnostic
centers and biotechnology companies. Currently pharmaceutical companies account for the
highest revenue share in the market followed by other end users. An increasing number of
multiplex assays labeled for research use only increase the growth prospects for academic
research institute end users in North America during the forecast period.
On the basis of region, the market has been segmented into North America, Latin America,
Europe, Asia-Pacific, and the MEA. This report assesses trends driving each market segment
and offers analysis and insights into the potential of multiplex detection immunoassay in specific
regions. North America is estimated to dominate the multiplex detection immunoa